| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $6.57 (Beat by $0.12) |
| EPS GAAP Actual | $6.57 (Beat by $0.12) |
| Revenue Actual | $12.215B |
| Revenue Surprise | Beat by $12215M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 36.24 | 14.55 | 35.80936 | 36.90835 | 1 |
| Dec 2029 | 36.3 | 14.52 | 35.60007 | 37.36258 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 5.22 | 5.22 | 12.215B | 6.71% | 12215M |
| FQ3 2025 (Sep 2025) | 4.28 | 4.28 | 11.122B | 4.71% | 11122M |
| FQ2 2025 (Jun 2025) | 4.28 | 4.28 | 10.855B | 2.89% | 10855M |
| FQ1 2025 (Mar 2025) | 3.99 | 3.99 | 10.364B | 0.18% | 10364M |
| FQ4 2024 (Dec 2024) | 4.79 | 4.79 | 11.395B | 4.47% | 11395M |
| FQ3 2024 (Sep 2024) | 4.27 | 4.27 | 10.598B | -0.84% | 10598M |
| FQ2 2024 (Jun 2024) | 4.05 | 4.05 | 10.541B | 100% | 10541M |
| FQ1 2024 (Mar 2024) | 3.48 | 3.48 | 10.345B | -3.53% | 10345M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 7.77247 | -- | 7.53307 | 7.91976 | 7 |
| FQ2 2028 (Jun 2028) | 7.23304 | -- | 7.01026 | 7.37011 | 7 |
| FQ1 2028 (Mar 2028) | 6.45233 | -- | 6.25359 | 6.57461 | 7 |
| FQ4 2027 (Dec 2027) | 7.61006 | -- | 7.45493 | 7.71889 | 10 |
| FQ3 2027 (Sep 2027) | 6.61238 | -- | 6.47758 | 6.70694 | 6 |
| FQ2 2027 (Jun 2027) | 6.47339 | -- | 6.34143 | 6.56596 | 12 |
| FQ1 2027 (Mar 2027) | 6.05031 | -- | 6.00155 | 6.12231 | 14 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 13.11B | -- | 12.8B | 13.31B | 6 |
| FQ2 2028 (Jun 2028) | 13.02B | -- | 12.72B | 13.21B | 5 |
| FQ1 2028 (Mar 2028) | 12.17B | -- | 11.88B | 12.35B | 5 |
| FQ4 2027 (Dec 2027) | 12.98B | -- | 12.78B | 13.13B | 9 |
| FQ3 2027 (Sep 2027) | 12.1B | -- | 11.91B | 12.23B | 6 |
| FQ2 2027 (Jun 2027) | 12.02B | -- | 11.83B | 12.16B | 5 |
| FQ1 2027 (Mar 2027) | 11.48B | -- | 11.4B | 11.58B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 5.22 | 5.22 | 100% | |
| FQ3 2025 (Sep 2025) | 4.28 | 4.28 | 100% | |
| FQ2 2025 (Jun 2025) | 4.28 | 4.28 | 100% | |
| FQ1 2025 (Mar 2025) | 3.99 | 3.99 | 100% | |
| FQ4 2024 (Dec 2024) | 4.79 | 4.79 | 100% | |
| FQ3 2024 (Sep 2024) | 4.27 | 4.27 | 100% | |
| FQ2 2024 (Jun 2024) | 4.05 | 4.05 | 100% | |
| FQ1 2024 (Mar 2024) | 3.48 | 3.48 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $12.22B | $12215M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $11.12B | $11122M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $10.86B | $10855M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $10.36B | $10364M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $11.4B | $11395M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $10.6B | $10598M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $10.54B | $10541M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $10.35B | $10345M | 100% |